evercyte: New mesenchymal stem cell lines from placental tissue for production of exosomes are now available!

Name: _pk_id Used for : Is used to store an unique ID for each user Duration : 13 Months
Name: &nbsp;_pk_ses, _pk_cvar, _pkhsr Used for :&nbsp;Session cookies that store temporary data Duration :&nbsp;30 minutes
Name: mtm_consent Used for : Stores cookie preferences Duration : 30 years

Mesenchymal stem cells from placental tissue and amniotic membrane have attracted much attention as they have been reported to exert therapeutic effects by e.g. promoting angiogenesis, inducing liver regeneration or influencing the immune system.

Evercyte is very pleased to present its new telomerized placenta- / amnion-derived cell lines which can be grown without limitations in vitro while maintaining cell type specific markers and functions. Moreover, our new cell lines have been established under xeno-free conditions with full documentation of any manipulation step and extracellular vesicles secreted by the cells under GMP conditions could provide new therapeutic approaches.

please contact us for more information: office(at)evercyte.com

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.

evercyte: New mesenchymal stem cell lines from placental tissue for production of exosomes are now available!

Das war das 18. qualityaustria Gesundheitsforum

„Healthy Lungs for Life“ setzt ein deutliches Zeichen für Lungengesundheit

vetmeduni Vienna: First Comprehensive Database of Food Metagenomes Developed